600518 ST康美药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.1061.465-31.860-2,597.984-622.990
总资产报酬率 ROA (%)0.0520.696-17.21932.069-55.032
投入资产回报率 ROIC (%)0.0811.107-27.00450.079-143.838

边际利润分析
销售毛利率 (%)14.43017.06715.14316.0443.427
营业利润率 (%)0.7981.778-42.523243.488-563.393
息税前利润/营业总收入 (%)0.7362.821-62.754222.028-532.911
净利润/营业总收入 (%)0.7172.125-64.443190.725-574.575

收益指标分析
经营活动净收益/利润总额(%)-719.314-18.66726.638-29.02613.464
价值变动净收益/利润总额(%)305.46840.229-0.0282.3150.015
营业外收支净额/利润总额(%)0.78021.47433.277-23.9791.748

偿债能力分析
流动比率 (X)1.4811.4551.3571.6750.796
速动比率 (X)0.8750.8900.8511.0290.551
资产负债率 (%)50.09450.41853.95937.908131.236
带息债务/全部投入资本 (%)-3.334-3.692-4.313-4.210--
股东权益/带息债务 (%)-2,291.823-2,069.085-1,733.971-2,220.407-34.540
股东权益/负债合计 (%)99.14397.88484.895163.111-24.090
利息保障倍数 (X)-10.7635.070-64.2378.661-13.156

营运能力分析
应收账款周转天数 (天)156.346147.504143.032163.0710.000
存货周转天数 (天)238.575240.218301.709459.7080.000